SFMBT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.087200E-01
Normal-vs-Stage2
8.824800E-01
Normal-vs-Stage3
9.056100E-02
Normal-vs-Stage4
3.359200E-01
Stage1-vs-Stage2
8.738400E-01
Stage1-vs-Stage3
4.204000E-02
Stage1-vs-Stage4
3.476800E-01
Stage2-vs-Stage3
2.213600E-04
Stage2-vs-Stage4
1.992600E-01
Stage3-vs-Stage4
4.875600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.552800E-01
Normal-vs-AfricanAmerican
7.849800E-01
Normal-vs-Asian
5.806000E-01
Caucasian-vs-AfricanAmerican
8.406600E-01
Caucasian-vs-Asian
1.787050E-01
AfricanAmerican-vs-Asian
2.979200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.647600E-01
Normal-vs-Female
9.323000E-01
Male-vs-Female
6.867400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.795200E-01
Normal-vs-Age(41-60Yrs)
6.484200E-01
Normal-vs-Age(61-80Yrs)
9.655200E-01
Normal-vs-Age(81-100Yrs)
3.873800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.940600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.779600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.180400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.491420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.275800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.727800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.622400E-01
Normal-vs-Daily Drinker
9.494200E-01
Normal-vs-Weekly Drinker
9.750400E-01
Normal-vs-Occasional Drinker
6.847400E-01
Normal-vs-Social Drinker
8.707600E-01
Non Drinker-vs-Daily Drinker
4.636000E-01
Non Drinker-vs-Weekly Drinker
6.376200E-01
Non Drinker-vs-Occasional Drinker
1.346960E-01
Non Drinker-vs-Social Drinker
3.718200E-01
Daily Drinker-vs-Weekly Drinker
8.650000E-01
Daily Drinker-vs-Occasional Drinker
4.729400E-01
Daily Drinker-vs-Social Drinker
8.752000E-01
Weekly Drinker-vs-Occasional Drinker
4.252800E-01
Weekly Drinker-vs-Social Drinker
7.488400E-01
Occasional Drinker-vs-Social Drinker
5.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.249200E-01
Normal-vs-Grade 2
2.512800E-01
Normal-vs-Grade 3
1.544000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.276400E-01
Grade 1-vs-Grade 3
5.683000E-01
Grade 1-vs-Grade 4
4.249200E-01
Grade 2-vs-Grade 3
4.328400E-01
Grade 2-vs-Grade 4
2.512800E-01
Grade 3-vs-Grade 4
1.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.264800E-01
Normal-vs-NonDiabetic
8.909200E-01
Diabetic-vs-NonDiabetic
2.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.972200E-01
Normal-vs-NoPancreatitis
9.880600E-01
Pancreatitis-vs-NoPancreatitis
5.000300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.212200E-01
Normal-vs-N1
8.784200E-01
N0-vs-N1
6.975400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.462600E-01
Normal-vs-TP53-NonMutant
7.782600E-01
TP53-Mutant-vs-TP53-NonMutant
1.605970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
